Dr. Tracy Patricia Marien, MD

Dr. Marien practices at Sharp Rees-Stealy Medical Group, Inc in San Diego, California.

Dr. Marien's NPI, 1902033517, was assigned on June 22, 2009. Dr. Marien graduated from New York University School of Medicine in 2009. Dr. Marien holds California license A143473.

Dr. Marien's primary practice is Sharp Rees-Stealy Medical Group, Inc, at 5651 Copley Dr, San Diego, CA 92111 in San Diego County. The practice phone is (858) 262-6666.

Dr. Marien's primary practice is Sharp Rees-Stealy Medical Group, Inc in San Diego, California. Dr. Marien is also affiliated with Sharp Memorial Hospital. The medical group on file is Sharp Rees-Stealy Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Marien practices. Vendor and product names are available with a free account.

Urology is Dr. Marien's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Marien is board certified in urology by the American Board of Urology. Dmand AI has Dr. Marien's licenses on file in 2 states: California and Tennessee.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), kidney removal surgery, kidney stone disease, prostate cancer, prostate inflammation or infection and urinary endoscopy among the conditions Dr. Marien treats.

CMS data shows 758 Medicare services from Dr. Marien across 13 procedure codes in 2024, for 218 Medicare patients. Medicare paid $53,511 for them.

CMS counts 218 Medicare patients who saw Dr. Marien in 2024. The largest group is 65 to 74, with 113 patients. 73% of them have high cholesterol, and 65% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.02, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Marien's median patient age at 69, with 31% women.

In 2024, Dr. Marien wrote 1,123 Medicare Part D claims for 307 patients. 95% of them were for generic drugs. CMS names the drug for 992 of them, across 18 drugs with 11 or more claims each, at $61,784 in total drug cost. In 2023, CMS named 748 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Marien for performance year 2024, reported as part of a group. Dr. Marien accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Marien as offering telehealth. CMS counts 26 procedures of prostate resection by Dr. Marien, more than 88% of the clinicians it reports for that procedure.

Dmand AI links 38 papers to Dr. Marien, published from 2012 to 2020. 2016 was the busiest year, with 9. The most frequent topics are Kidney Calculi, Ureteroscopy and Postoperative Complications. Dr. Marien has published most often in J Urol. Dr. Marien's most frequent co-authors are Ojas Shah, MD, Mitchell R. Humphreys, MD and Cameron M. Charchenko, MD.

CMS Open Payments shows 38 general payments to Dr. Marien from 14 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 50% of the total. NeoTract Inc. paid the most, $2,842.

Dr. Marien graduated from New York University School of Medicine in 2009.

Dr. Marien is in network with 6 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.